Practice
The resurgence of pertussis
J. Brad Wiggers, Jerome A. Leis and Wayne L. Gold
CMAJ July 14, 2015 187 (10) 755; DOI: https://doi.org/10.1503/cmaj.140896
J. Brad Wiggers
Department of Medicine (Wiggers), University of Toronto; Division of Infectious Diseases (Leis, Gold), Department of Medicine, University of Toronto; Centre for Quality Improvement and Patient Safety (Leis), University of Toronto, Toronto, Ont.
MDJerome A. Leis
Department of Medicine (Wiggers), University of Toronto; Division of Infectious Diseases (Leis, Gold), Department of Medicine, University of Toronto; Centre for Quality Improvement and Patient Safety (Leis), University of Toronto, Toronto, Ont.
MD MScWayne L. Gold
Department of Medicine (Wiggers), University of Toronto; Division of Infectious Diseases (Leis, Gold), Department of Medicine, University of Toronto; Centre for Quality Improvement and Patient Safety (Leis), University of Toronto, Toronto, Ont.
MDArticle Figures & Tables
There are no figures or tables available.
In this issue
Article tools
Respond to this article
The resurgence of pertussis
J. Brad Wiggers, Jerome A. Leis, Wayne L. Gold
CMAJ Jul 2015, 187 (10) 755; DOI: 10.1503/cmaj.140896
Jump to section
- Article
- Pertussis is a highly communicable respiratory tract infection
- The resurgence of pertussis has been linked to waning immunity
- The diagnostic test of choice is polymerase chain reaction testing of a nasopharyngeal aspirate
- Macrolides are the mainstay of therapy and prophylaxis
- Pertussis vaccines are indicated for children, adolescents and adults
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.